

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.49265037 |
| 2 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.14130193 |
| 3 | glutamate secretion (GO:0014047) | 4.62517317 |
| 4 | neuronal action potential propagation (GO:0019227) | 4.60874749 |
| 5 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.49235852 |
| 6 | ATP hydrolysis coupled proton transport (GO:0015991) | 4.49235852 |
| 7 | transferrin transport (GO:0033572) | 4.42326665 |
| 8 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.35943985 |
| 9 | * regulation of synaptic vesicle exocytosis (GO:2000300) | 4.14084432 |
| 10 | ferric iron transport (GO:0015682) | 4.11435708 |
| 11 | trivalent inorganic cation transport (GO:0072512) | 4.11435708 |
| 12 | protein localization to synapse (GO:0035418) | 4.05033291 |
| 13 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.97238514 |
| 14 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.89593875 |
| 15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.82441948 |
| 16 | negative regulation of cell killing (GO:0031342) | 3.82441948 |
| 17 | Golgi transport vesicle coating (GO:0048200) | 3.69896727 |
| 18 | COPI coating of Golgi vesicle (GO:0048205) | 3.69896727 |
| 19 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.69564889 |
| 20 | neuron cell-cell adhesion (GO:0007158) | 3.68866121 |
| 21 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.68731907 |
| 22 | synaptic vesicle maturation (GO:0016188) | 3.68413251 |
| 23 | * regulation of synaptic vesicle transport (GO:1902803) | 3.68373353 |
| 24 | presynaptic membrane assembly (GO:0097105) | 3.60594679 |
| 25 | cellular response to type I interferon (GO:0071357) | 3.55962790 |
| 26 | type I interferon signaling pathway (GO:0060337) | 3.55962790 |
| 27 | presynaptic membrane organization (GO:0097090) | 3.55591037 |
| 28 | vocalization behavior (GO:0071625) | 3.54590551 |
| 29 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.54099784 |
| 30 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.52284515 |
| 31 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.51173928 |
| 32 | response to type I interferon (GO:0034340) | 3.50251579 |
| 33 | positive regulation of synapse maturation (GO:0090129) | 3.48563001 |
| 34 | neurotransmitter secretion (GO:0007269) | 3.47846103 |
| 35 | neutrophil activation involved in immune response (GO:0002283) | 3.42193602 |
| 36 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.40532489 |
| 37 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.40427560 |
| 38 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.38135348 |
| 39 | long-term synaptic potentiation (GO:0060291) | 3.37090392 |
| 40 | postsynaptic membrane organization (GO:0001941) | 3.36380285 |
| 41 | response to peptidoglycan (GO:0032494) | 3.36282548 |
| 42 | protein maturation by protein folding (GO:0022417) | 3.35232420 |
| 43 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.30608804 |
| 44 | urinary tract smooth muscle contraction (GO:0014848) | 3.28694375 |
| 45 | phagosome maturation (GO:0090382) | 3.27415522 |
| 46 | immunoglobulin mediated immune response (GO:0016064) | 3.26523154 |
| 47 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.25160936 |
| 48 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.23148418 |
| 49 | NADH metabolic process (GO:0006734) | 3.22935157 |
| 50 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.20830486 |
| 51 | macrophage activation involved in immune response (GO:0002281) | 3.20708593 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.19920221 |
| 53 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.18701764 |
| 54 | negative regulation of interleukin-12 production (GO:0032695) | 3.18527153 |
| 55 | negative regulation of cation channel activity (GO:2001258) | 3.15407388 |
| 56 | positive regulation by symbiont of host defense response (GO:0052509) | 3.15098890 |
| 57 | modulation by symbiont of host defense response (GO:0052031) | 3.15098890 |
| 58 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.15098890 |
| 59 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.15098890 |
| 60 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.15098890 |
| 61 | modulation by symbiont of host immune response (GO:0052553) | 3.15098890 |
| 62 | detection of calcium ion (GO:0005513) | 3.07278608 |
| 63 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.06854025 |
| 64 | * neuron-neuron synaptic transmission (GO:0007270) | 3.05747166 |
| 65 | cullin deneddylation (GO:0010388) | 3.05015914 |
| 66 | regulation of vesicle fusion (GO:0031338) | 3.02090093 |
| 67 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.02044629 |
| 68 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.01018535 |
| 69 | serotonin metabolic process (GO:0042428) | 3.00064707 |
| 70 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.99896948 |
| 71 | establishment of synaptic vesicle localization (GO:0097480) | 2.98805574 |
| 72 | synaptic vesicle transport (GO:0048489) | 2.98805574 |
| 73 | positive regulation of membrane potential (GO:0045838) | 2.97692365 |
| 74 | signal peptide processing (GO:0006465) | 2.93869647 |
| 75 | detection of bacterium (GO:0016045) | 2.91159163 |
| 76 | detection of other organism (GO:0098543) | 2.89469719 |
| 77 | synaptic vesicle endocytosis (GO:0048488) | 2.88616585 |
| 78 | positive regulation of type 2 immune response (GO:0002830) | 2.86037220 |
| 79 | regulation of synaptic plasticity (GO:0048167) | 2.85206633 |
| 80 | * regulation of neurotransmitter secretion (GO:0046928) | 2.83052775 |
| 81 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.82194195 |
| 82 | neurotransmitter transport (GO:0006836) | 2.82194177 |
| 83 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.82071997 |
| 84 | neuromuscular process controlling posture (GO:0050884) | 2.81399451 |
| 85 | protein complex biogenesis (GO:0070271) | 2.80994512 |
| 86 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.80460327 |
| 87 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.79067701 |
| 88 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.78785422 |
| 89 | behavioral response to cocaine (GO:0048148) | 2.78656820 |
| 90 | striatum development (GO:0021756) | 2.78583345 |
| 91 | * synaptic transmission, glutamatergic (GO:0035249) | 2.78574936 |
| 92 | calcium ion-dependent exocytosis (GO:0017156) | 2.78515296 |
| 93 | vesicle docking involved in exocytosis (GO:0006904) | 2.78256769 |
| 94 | regulation of synapse maturation (GO:0090128) | 2.78134843 |
| 95 | cerebellar granule cell differentiation (GO:0021707) | 2.78001764 |
| 96 | NIK/NF-kappaB signaling (GO:0038061) | 2.77541058 |
| 97 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.77409154 |
| 98 | positive regulation of neurotransmitter transport (GO:0051590) | 2.75529569 |
| 99 | inositol phosphate catabolic process (GO:0071545) | 2.75507458 |
| 100 | protein deneddylation (GO:0000338) | 2.75374726 |
| 101 | glutamate receptor signaling pathway (GO:0007215) | 2.73954338 |
| 102 | membrane depolarization during action potential (GO:0086010) | 2.72778244 |
| 103 | response to pheromone (GO:0019236) | 2.72513904 |
| 104 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.71093314 |
| 105 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.70234047 |
| 106 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.70065255 |
| 107 | insulin secretion (GO:0030073) | 2.69899402 |
| 108 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.68630544 |
| 109 | protein localization to endosome (GO:0036010) | 2.67512581 |
| 110 | ER overload response (GO:0006983) | 2.67285601 |
| 111 | regulation of glutamate secretion (GO:0014048) | 2.67035662 |
| 112 | * regulation of neurotransmitter transport (GO:0051588) | 2.65889473 |
| 113 | chaperone-mediated protein transport (GO:0072321) | 2.65849246 |
| 114 | germinal center formation (GO:0002467) | 2.65763755 |
| 115 | regulation of type 2 immune response (GO:0002828) | 2.65297018 |
| 116 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.65055331 |
| 117 | regulation of postsynaptic membrane potential (GO:0060078) | 2.65027631 |
| 118 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.64137606 |
| 119 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.63612916 |
| 120 | establishment of vesicle localization (GO:0051650) | 2.63354928 |
| 121 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.63351029 |
| 122 | regulation of mast cell degranulation (GO:0043304) | 2.62443616 |
| 123 | positive regulation of exocytosis (GO:0045921) | 2.61953842 |
| 124 | positive regulation of synaptic transmission (GO:0050806) | 2.61201552 |
| 125 | oxaloacetate metabolic process (GO:0006107) | 2.60739149 |
| 126 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.59716507 |
| 127 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.59473544 |
| 128 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.59473544 |
| 129 | * synaptic transmission (GO:0007268) | 2.57265812 |
| 130 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.56304335 |
| 131 | locomotory exploration behavior (GO:0035641) | 2.56209285 |
| 132 | establishment of melanosome localization (GO:0032401) | 2.56120873 |
| 133 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.54122300 |
| 134 | melanosome transport (GO:0032402) | 2.53996525 |
| 135 | GDP-mannose metabolic process (GO:0019673) | 2.53823269 |
| 136 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.53583184 |
| 137 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.53304901 |
| 138 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.51255487 |
| 139 | granulocyte activation (GO:0036230) | 2.49658030 |
| 140 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.49048846 |
| 141 | barbed-end actin filament capping (GO:0051016) | 2.48224095 |
| 142 | regulation of leukocyte degranulation (GO:0043300) | 2.45651238 |
| 143 | regulation of defense response to virus by virus (GO:0050690) | 2.45310305 |
| 144 | myeloid dendritic cell differentiation (GO:0043011) | 2.43885683 |
| 145 | myeloid cell activation involved in immune response (GO:0002275) | 2.43103459 |
| 146 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.42893157 |
| 147 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.42747226 |
| 148 | regulation of regulated secretory pathway (GO:1903305) | 2.42658522 |
| 149 | detection of external biotic stimulus (GO:0098581) | 2.42327162 |
| 150 | regulation of gamma-delta T cell activation (GO:0046643) | 2.42160226 |
| 151 | negative regulation of innate immune response (GO:0045824) | 2.40682919 |
| 152 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.40669860 |
| 153 | activation of MAPKKK activity (GO:0000185) | 2.40512300 |
| 154 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.39619581 |
| 155 | response to host immune response (GO:0052572) | 2.37119593 |
| 156 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.37119593 |
| 157 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.36349422 |
| 158 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.35918176 |
| 159 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.35259116 |
| 160 | mature B cell differentiation involved in immune response (GO:0002313) | 2.33101579 |
| 161 | modulation by symbiont of host cellular process (GO:0044068) | 2.32349671 |
| 162 | leukocyte aggregation (GO:0070486) | 2.31884429 |
| 163 | response to muramyl dipeptide (GO:0032495) | 2.29272851 |
| 164 | neutrophil activation (GO:0042119) | 2.28529182 |
| 165 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.28495660 |
| 166 | adenosine receptor signaling pathway (GO:0001973) | 2.28215785 |
| 167 | regulation of ARF protein signal transduction (GO:0032012) | 2.27829754 |
| 168 | negative regulation of type 2 immune response (GO:0002829) | 2.27223059 |
| 169 | defense response to protozoan (GO:0042832) | 2.26734603 |
| 170 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.26066346 |
| 171 | signal complex assembly (GO:0007172) | 2.26014191 |
| 172 | lymphocyte chemotaxis (GO:0048247) | 2.24315522 |
| 173 | regulation of T cell tolerance induction (GO:0002664) | 2.22206682 |
| 174 | negative regulation of T cell mediated immunity (GO:0002710) | 2.22090832 |
| 175 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.21119084 |
| 176 | cellular response to virus (GO:0098586) | 2.21035999 |
| 177 | macrophage activation (GO:0042116) | 2.20943940 |
| 178 | B cell mediated immunity (GO:0019724) | 2.20354824 |
| 179 | response to protozoan (GO:0001562) | 2.19563547 |
| 180 | amino sugar catabolic process (GO:0046348) | 2.17764204 |
| 181 | regulation of early endosome to late endosome transport (GO:2000641) | 2.16279659 |
| 182 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.16165280 |
| 183 | response to thyroid hormone (GO:0097066) | 2.14599277 |
| 184 | detection of molecule of bacterial origin (GO:0032490) | 2.14165061 |
| 185 | response to host (GO:0075136) | 2.12793841 |
| 186 | response to host defenses (GO:0052200) | 2.12793841 |
| 187 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.12793841 |
| 188 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.12657187 |
| 189 | positive regulation of protein dephosphorylation (GO:0035307) | 2.12055557 |
| 190 | glycosphingolipid catabolic process (GO:0046479) | 2.12047082 |
| 191 | actin filament polymerization (GO:0030041) | 2.11960974 |
| 192 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.11918276 |
| 193 | T cell migration (GO:0072678) | 2.11078193 |
| 194 | regulation of antigen processing and presentation (GO:0002577) | 2.10797793 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.26644829 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.23376155 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.19378372 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.12099453 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.00289291 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.98758348 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.89952367 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.80893531 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.75912123 |
| 10 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.70750157 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.62122065 |
| 12 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.61173137 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.57982960 |
| 14 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.57899068 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.46458506 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.43123136 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.38699278 |
| 18 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.32722523 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.32165643 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.29849583 |
| 21 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.28590118 |
| 22 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.27515928 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26428133 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.18486662 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.17915220 |
| 26 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.16986461 |
| 27 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.12938754 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.12546864 |
| 29 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.11140108 |
| 30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.08724714 |
| 31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.07176975 |
| 32 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.07172903 |
| 33 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.07172903 |
| 34 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.06114210 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.05151919 |
| 36 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.03469412 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.98917741 |
| 38 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.97418213 |
| 39 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.96729729 |
| 40 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.96257782 |
| 41 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.95940685 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.95923668 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.92603591 |
| 44 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.89386371 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.89053873 |
| 46 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.82388256 |
| 47 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81900855 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.80966248 |
| 49 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.78583925 |
| 50 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.77208021 |
| 51 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.76765042 |
| 52 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.75947328 |
| 53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.72393027 |
| 54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71992990 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.71610245 |
| 56 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.71248113 |
| 57 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.69419675 |
| 58 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68947389 |
| 59 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.68848095 |
| 60 | MYC_22102868_ChIP-Seq_BL_Human | 1.67382728 |
| 61 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64474642 |
| 62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.63671740 |
| 63 | MAF_26560356_Chip-Seq_TH1_Human | 1.63635686 |
| 64 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.63196896 |
| 65 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.62792042 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61409917 |
| 67 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.59826323 |
| 68 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.59746598 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.59723686 |
| 70 | SPI1_23127762_ChIP-Seq_K562_Human | 1.59410638 |
| 71 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.59119230 |
| 72 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.57467167 |
| 73 | P68_20966046_ChIP-Seq_HELA_Human | 1.55474269 |
| 74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.54348182 |
| 75 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.54251142 |
| 76 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53194509 |
| 77 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.52579334 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51514839 |
| 79 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.50708287 |
| 80 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.50447057 |
| 81 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.50002811 |
| 82 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.48895310 |
| 83 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.47815309 |
| 84 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47373383 |
| 85 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.47131496 |
| 86 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.46970630 |
| 87 | VDR_22108803_ChIP-Seq_LS180_Human | 1.46544416 |
| 88 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.45239558 |
| 89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45036372 |
| 90 | KDM2B_26808549_Chip-Seq_K562_Human | 1.42714376 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42436720 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 1.40890904 |
| 93 | MAF_26560356_Chip-Seq_TH2_Human | 1.40800307 |
| 94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.39192866 |
| 95 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.38577392 |
| 96 | P300_19829295_ChIP-Seq_ESCs_Human | 1.38188557 |
| 97 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37989096 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37210687 |
| 99 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.36754472 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36609486 |
| 101 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.36123385 |
| 102 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.35467030 |
| 103 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.35402593 |
| 104 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.34798516 |
| 105 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.34477395 |
| 106 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.34403005 |
| 107 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34164302 |
| 108 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32952615 |
| 109 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.31623535 |
| 110 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.28373993 |
| 111 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27160569 |
| 112 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26707025 |
| 113 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26536166 |
| 114 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.26034561 |
| 115 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.25708510 |
| 116 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.24360362 |
| 117 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.23382202 |
| 118 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.22727861 |
| 119 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22224674 |
| 120 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21822292 |
| 121 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20842562 |
| 122 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.18435110 |
| 123 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.18169969 |
| 124 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.17367668 |
| 125 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.17073079 |
| 126 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16514519 |
| 127 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.16141284 |
| 128 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15862266 |
| 129 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.15691611 |
| 130 | SA1_27219007_Chip-Seq_Bcells_Human | 1.15419063 |
| 131 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.14148573 |
| 132 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14034805 |
| 133 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13947271 |
| 134 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13483003 |
| 135 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.12902486 |
| 136 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.12203564 |
| 137 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.11745039 |
| 138 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.10695465 |
| 139 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10588579 |
| 140 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09966623 |
| 141 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08981912 |
| 142 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08595288 |
| 143 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.08043126 |
| 144 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.06752072 |
| 145 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05919162 |
| 146 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.05691737 |
| 147 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05167135 |
| 148 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04440030 |
| 149 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.03764956 |
| 150 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.03362356 |
| 151 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03269651 |
| 152 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02897585 |
| 153 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02253961 |
| 154 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01987366 |
| 155 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01914368 |
| 156 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.00504317 |
| 157 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.99841110 |
| 158 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99348926 |
| 159 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98312969 |
| 160 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.96572850 |
| 161 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.96284775 |
| 162 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96069617 |
| 163 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.95490641 |
| 164 | JUN_21703547_ChIP-Seq_K562_Human | 0.94964951 |
| 165 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91556417 |
| 166 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.90336683 |
| 167 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.89133061 |
| 168 | TCF4_23295773_ChIP-Seq_U87_Human | 0.88387043 |
| 169 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.87836103 |
| 170 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.87202767 |
| 171 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.86807605 |
| 172 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.85744821 |
| 173 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.85187293 |
| 174 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84715597 |
| 175 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.84280070 |
| 176 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.83703296 |
| 177 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.82205861 |
| 178 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.81466136 |
| 179 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.81466136 |
| 180 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.81400349 |
| 181 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.80980036 |
| 182 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.80337551 |
| 183 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80098622 |
| 184 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.79906563 |
| 185 | * TP53_22573176_ChIP-Seq_HFKS_Human | 0.79300655 |
| 186 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.78143429 |
| 187 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.78102953 |
| 188 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.77020989 |
| 189 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.77014068 |
| 190 | AR_19668381_ChIP-Seq_PC3_Human | 0.76932066 |
| 191 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.76114755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.15500571 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.09238431 |
| 3 | MP0003303_peritoneal_inflammation | 4.03188734 |
| 4 | MP0001968_abnormal_touch/_nociception | 3.37880552 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.35039484 |
| 6 | MP0004270_analgesia | 3.32723365 |
| 7 | MP0003436_decreased_susceptibility_to | 3.27708156 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 3.16271409 |
| 9 | MP0002736_abnormal_nociception_after | 3.11466262 |
| 10 | MP0003724_increased_susceptibility_to | 3.04870316 |
| 11 | MP0009046_muscle_twitch | 2.96891992 |
| 12 | MP0002735_abnormal_chemical_nociception | 2.89243858 |
| 13 | MP0002064_seizures | 2.85201112 |
| 14 | MP0003183_abnormal_peptide_metabolism | 2.83493209 |
| 15 | MP0009745_abnormal_behavioral_response | 2.83367184 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.75255186 |
| 17 | MP0006082_CNS_inflammation | 2.70067200 |
| 18 | MP0009840_abnormal_foam_cell | 2.67717953 |
| 19 | MP0002272_abnormal_nervous_system | 2.54361488 |
| 20 | MP0004510_myositis | 2.53211818 |
| 21 | MP0002063_abnormal_learning/memory/cond | 2.52494223 |
| 22 | MP0009785_altered_susceptibility_to | 2.50907816 |
| 23 | MP0010386_abnormal_urinary_bladder | 2.50685842 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.49225959 |
| 25 | MP0001835_abnormal_antigen_presentation | 2.46102674 |
| 26 | MP0005451_abnormal_body_composition | 2.45451249 |
| 27 | MP0000013_abnormal_adipose_tissue | 2.43303568 |
| 28 | MP0005000_abnormal_immune_tolerance | 2.41119751 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 2.39130517 |
| 30 | MP0005025_abnormal_response_to | 2.36835497 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 2.33675209 |
| 32 | MP0003075_altered_response_to | 2.31434505 |
| 33 | MP0005464_abnormal_platelet_physiology | 2.31220594 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 2.26426328 |
| 35 | MP0005671_abnormal_response_to | 2.23050091 |
| 36 | MP0002419_abnormal_innate_immunity | 2.21795016 |
| 37 | MP0005646_abnormal_pituitary_gland | 2.17601394 |
| 38 | MP0003879_abnormal_hair_cell | 2.16991062 |
| 39 | MP0009780_abnormal_chondrocyte_physiolo | 2.14061713 |
| 40 | MP0002822_catalepsy | 2.10739978 |
| 41 | MP0005387_immune_system_phenotype | 2.10518626 |
| 42 | MP0001790_abnormal_immune_system | 2.10518626 |
| 43 | MP0001970_abnormal_pain_threshold | 2.10258752 |
| 44 | MP0001984_abnormal_olfaction | 2.06593907 |
| 45 | MP0002733_abnormal_thermal_nociception | 2.05047854 |
| 46 | MP0003300_gastrointestinal_ulcer | 2.00009656 |
| 47 | MP0004043_abnormal_pH_regulation | 1.98248730 |
| 48 | MP0001501_abnormal_sleep_pattern | 1.97252519 |
| 49 | MP0002909_abnormal_adrenal_gland | 1.97104465 |
| 50 | * MP0002067_abnormal_sensory_capabilities | 1.95907486 |
| 51 | MP0006276_abnormal_autonomic_nervous | 1.90118085 |
| 52 | MP0003122_maternal_imprinting | 1.85063409 |
| 53 | MP0002723_abnormal_immune_serum | 1.84393386 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.83403167 |
| 55 | MP0004947_skin_inflammation | 1.83287538 |
| 56 | MP0000604_amyloidosis | 1.82128356 |
| 57 | MP0000685_abnormal_immune_system | 1.80984848 |
| 58 | MP0001800_abnormal_humoral_immune | 1.76094187 |
| 59 | MP0002876_abnormal_thyroid_physiology | 1.74576198 |
| 60 | MP0009278_abnormal_bone_marrow | 1.74085859 |
| 61 | MP0001986_abnormal_taste_sensitivity | 1.73485640 |
| 62 | MP0002452_abnormal_antigen_presenting | 1.71827107 |
| 63 | MP0002420_abnormal_adaptive_immunity | 1.66413414 |
| 64 | MP0001819_abnormal_immune_cell | 1.65464708 |
| 65 | MP0008569_lethality_at_weaning | 1.65336590 |
| 66 | MP0000343_altered_response_to | 1.64790398 |
| 67 | MP0003787_abnormal_imprinting | 1.62453148 |
| 68 | MP0002163_abnormal_gland_morphology | 1.62034389 |
| 69 | MP0005379_endocrine/exocrine_gland_phen | 1.59617558 |
| 70 | MP0003329_amyloid_beta_deposits | 1.58288076 |
| 71 | MP0004142_abnormal_muscle_tone | 1.55725505 |
| 72 | MP0001529_abnormal_vocalization | 1.55694906 |
| 73 | MP0001486_abnormal_startle_reflex | 1.54519841 |
| 74 | MP0001440_abnormal_grooming_behavior | 1.54416332 |
| 75 | MP0002184_abnormal_innervation | 1.53311435 |
| 76 | MP0005166_decreased_susceptibility_to | 1.51478838 |
| 77 | MP0009764_decreased_sensitivity_to | 1.49203874 |
| 78 | MP0003690_abnormal_glial_cell | 1.48967352 |
| 79 | MP0001845_abnormal_inflammatory_respons | 1.45812712 |
| 80 | MP0010155_abnormal_intestine_physiology | 1.45200756 |
| 81 | MP0001502_abnormal_circadian_rhythm | 1.44342305 |
| 82 | MP0001905_abnormal_dopamine_level | 1.41433336 |
| 83 | MP0009333_abnormal_splenocyte_physiolog | 1.37116350 |
| 84 | MP0005397_hematopoietic_system_phenotyp | 1.36830218 |
| 85 | MP0001545_abnormal_hematopoietic_system | 1.36830218 |
| 86 | MP0004858_abnormal_nervous_system | 1.35738767 |
| 87 | MP0008469_abnormal_protein_level | 1.34210700 |
| 88 | MP0004811_abnormal_neuron_physiology | 1.31251422 |
| 89 | MP0000920_abnormal_myelination | 1.30813287 |
| 90 | MP0008874_decreased_physiological_sensi | 1.30161190 |
| 91 | MP0003806_abnormal_nucleotide_metabolis | 1.29660616 |
| 92 | MP0004924_abnormal_behavior | 1.29245287 |
| 93 | MP0005386_behavior/neurological_phenoty | 1.29245287 |
| 94 | MP0005645_abnormal_hypothalamus_physiol | 1.28991718 |
| 95 | MP0002557_abnormal_social/conspecific_i | 1.28351504 |
| 96 | MP0002139_abnormal_hepatobiliary_system | 1.28210029 |
| 97 | MP0003763_abnormal_thymus_physiology | 1.27676033 |
| 98 | MP0005551_abnormal_eye_electrophysiolog | 1.27099367 |
| 99 | MP0008260_abnormal_autophagy | 1.26966816 |
| 100 | MP0000858_altered_metastatic_potential | 1.26334426 |
| 101 | MP0002638_abnormal_pupillary_reflex | 1.24169237 |
| 102 | MP0003656_abnormal_erythrocyte_physiolo | 1.22584244 |
| 103 | MP0000716_abnormal_immune_system | 1.22374532 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 1.21168557 |
| 105 | MP0002998_abnormal_bone_remodeling | 1.20944095 |
| 106 | MP0002693_abnormal_pancreas_physiology | 1.20317600 |
| 107 | * MP0002066_abnormal_motor_capabilities/c | 1.18927722 |
| 108 | MP0003866_abnormal_defecation | 1.18825689 |
| 109 | MP0002398_abnormal_bone_marrow | 1.17834553 |
| 110 | MP0000749_muscle_degeneration | 1.16897863 |
| 111 | * MP0002882_abnormal_neuron_morphology | 1.13979829 |
| 112 | MP0002405_respiratory_system_inflammati | 1.13780117 |
| 113 | MP0001853_heart_inflammation | 1.12811802 |
| 114 | MP0004145_abnormal_muscle_electrophysio | 1.12668582 |
| 115 | MP0005310_abnormal_salivary_gland | 1.12528488 |
| 116 | MP0005171_absent_coat_pigmentation | 1.12252531 |
| 117 | MP0002229_neurodegeneration | 1.11446384 |
| 118 | MP0004233_abnormal_muscle_weight | 1.10286938 |
| 119 | * MP0000955_abnormal_spinal_cord | 1.08872180 |
| 120 | MP0001188_hyperpigmentation | 1.08469005 |
| 121 | MP0003195_calcinosis | 1.08263876 |
| 122 | MP0000751_myopathy | 1.08052275 |
| 123 | MP0002332_abnormal_exercise_endurance | 1.00649459 |
| 124 | MP0002429_abnormal_blood_cell | 1.00400721 |
| 125 | MP0003633_abnormal_nervous_system | 1.00031029 |
| 126 | MP0003453_abnormal_keratinocyte_physiol | 0.98116490 |
| 127 | MP0001664_abnormal_digestion | 0.95757603 |
| 128 | MP0005165_increased_susceptibility_to | 0.95439936 |
| 129 | MP0001944_abnormal_pancreas_morphology | 0.95123004 |
| 130 | MP0008004_abnormal_stomach_pH | 0.93733325 |
| 131 | MP0003448_altered_tumor_morphology | 0.93549095 |
| 132 | MP0006036_abnormal_mitochondrial_physio | 0.93541568 |
| 133 | MP0000678_abnormal_parathyroid_gland | 0.92485654 |
| 134 | MP0008872_abnormal_physiological_respon | 0.92349769 |
| 135 | MP0005535_abnormal_body_temperature | 0.91931967 |
| 136 | MP0006072_abnormal_retinal_apoptosis | 0.91196260 |
| 137 | MP0000465_gastrointestinal_hemorrhage | 0.90277777 |
| 138 | MP0002069_abnormal_eating/drinking_beha | 0.89778168 |
| 139 | MP0003705_abnormal_hypodermis_morpholog | 0.89302243 |
| 140 | MP0009763_increased_sensitivity_to | 0.88607612 |
| 141 | MP0002722_abnormal_immune_system | 0.88030277 |
| 142 | MP0003045_fibrosis | 0.87798555 |
| 143 | MP0000689_abnormal_spleen_morphology | 0.86655440 |
| 144 | MP0004036_abnormal_muscle_relaxation | 0.83712394 |
| 145 | MP0002078_abnormal_glucose_homeostasis | 0.83504957 |
| 146 | MP0005423_abnormal_somatic_nervous | 0.83032462 |
| 147 | MP0002751_abnormal_autonomic_nervous | 0.80673007 |
| 148 | MP0003631_nervous_system_phenotype | 0.80482856 |
| 149 | MP0001542_abnormal_bone_strength | 0.79728121 |
| 150 | MP0002090_abnormal_vision | 0.79260055 |
| 151 | MP0001765_abnormal_ion_homeostasis | 0.78432064 |
| 152 | MP0003172_abnormal_lysosome_physiology | 0.77886927 |
| 153 | MP0001963_abnormal_hearing_physiology | 0.77327636 |
| 154 | MP0001851_eye_inflammation | 0.76921413 |
| 155 | MP0004085_abnormal_heartbeat | 0.75469226 |
| 156 | MP0005390_skeleton_phenotype | 0.75259092 |
| 157 | MP0000003_abnormal_adipose_tissue | 0.73860190 |
| 158 | MP0006035_abnormal_mitochondrial_morpho | 0.72132773 |
| 159 | MP0003283_abnormal_digestive_organ | 0.71179192 |
| 160 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71117836 |
| 161 | MP0000681_abnormal_thyroid_gland | 0.69611161 |
| 162 | MP0003634_abnormal_glial_cell | 0.69196881 |
| 163 | MP0000631_abnormal_neuroendocrine_gland | 0.68477411 |
| 164 | MP0002132_abnormal_respiratory_system | 0.68387406 |
| 165 | MP0002877_abnormal_melanocyte_morpholog | 0.68315648 |
| 166 | MP0005499_abnormal_olfactory_system | 0.68194994 |
| 167 | MP0005394_taste/olfaction_phenotype | 0.68194994 |
| 168 | MP0003279_aneurysm | 0.68040125 |
| 169 | MP0000230_abnormal_systemic_arterial | 0.67367428 |
| 170 | MP0004215_abnormal_myocardial_fiber | 0.67260541 |
| 171 | MP0005666_abnormal_adipose_tissue | 0.67108363 |
| 172 | MP0001663_abnormal_digestive_system | 0.66946313 |
| 173 | MP0005365_abnormal_bile_salt | 0.65834505 |
| 174 | MP0004147_increased_porphyrin_level | 0.65669498 |
| 175 | MP0003953_abnormal_hormone_level | 0.65190956 |
| 176 | MP0002752_abnormal_somatic_nervous | 0.65038705 |
| 177 | MP0003795_abnormal_bone_structure | 0.62010499 |
| 178 | MP0000747_muscle_weakness | 0.61584045 |
| 179 | MP0003828_pulmonary_edema | 0.60275865 |
| 180 | MP0002118_abnormal_lipid_homeostasis | 0.59765055 |
| 181 | MP0005164_abnormal_response_to | 0.59032558 |
| 182 | MP0000249_abnormal_blood_vessel | 0.57307202 |
| 183 | MP0000609_abnormal_liver_physiology | 0.56253818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.94179502 |
| 2 | Atonic seizures (HP:0010819) | 4.95780945 |
| 3 | Epileptic encephalopathy (HP:0200134) | 4.91129503 |
| 4 | Pheochromocytoma (HP:0002666) | 4.11110408 |
| 5 | Neuroendocrine neoplasm (HP:0100634) | 4.05680438 |
| 6 | Eczematoid dermatitis (HP:0000976) | 3.98594747 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.96122265 |
| 8 | Visual hallucinations (HP:0002367) | 3.86628707 |
| 9 | Myokymia (HP:0002411) | 3.86532171 |
| 10 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.84198379 |
| 11 | Febrile seizures (HP:0002373) | 3.81388185 |
| 12 | Acute necrotizing encephalopathy (HP:0006965) | 3.80874651 |
| 13 | Absence seizures (HP:0002121) | 3.71676468 |
| 14 | Focal seizures (HP:0007359) | 3.60769061 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 3.58476148 |
| 16 | Dialeptic seizures (HP:0011146) | 3.41920630 |
| 17 | Purpura (HP:0000979) | 3.28865140 |
| 18 | Myositis (HP:0100614) | 3.25354855 |
| 19 | Hyperventilation (HP:0002883) | 3.20576089 |
| 20 | Orchitis (HP:0100796) | 3.18993693 |
| 21 | Mitochondrial inheritance (HP:0001427) | 3.18701421 |
| 22 | Petechiae (HP:0000967) | 3.17196280 |
| 23 | Hypothermia (HP:0002045) | 3.13449350 |
| 24 | Loss of speech (HP:0002371) | 3.05255601 |
| 25 | Progressive macrocephaly (HP:0004481) | 3.04537015 |
| 26 | Increased cerebral lipofuscin (HP:0011813) | 3.03168280 |
| 27 | Recurrent abscess formation (HP:0002722) | 3.02162764 |
| 28 | Abnormal hair whorl (HP:0010721) | 3.01825121 |
| 29 | Recurrent bacterial skin infections (HP:0005406) | 2.99667006 |
| 30 | Acute encephalopathy (HP:0006846) | 2.96267147 |
| 31 | Generalized tonic-clonic seizures (HP:0002069) | 2.90938698 |
| 32 | Hepatocellular necrosis (HP:0001404) | 2.90837037 |
| 33 | Optic neuritis (HP:0100653) | 2.86807066 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 2.86807066 |
| 35 | Progressive cerebellar ataxia (HP:0002073) | 2.86211410 |
| 36 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.84560703 |
| 37 | Increased IgE level (HP:0003212) | 2.83957759 |
| 38 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.81591527 |
| 39 | Mutism (HP:0002300) | 2.79359024 |
| 40 | Increased CSF lactate (HP:0002490) | 2.78025526 |
| 41 | Medial flaring of the eyebrow (HP:0010747) | 2.71813629 |
| 42 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.69630475 |
| 43 | Epileptiform EEG discharges (HP:0011182) | 2.69430230 |
| 44 | Gait imbalance (HP:0002141) | 2.68675436 |
| 45 | Neurofibrillary tangles (HP:0002185) | 2.68220071 |
| 46 | Nephrogenic diabetes insipidus (HP:0009806) | 2.67770534 |
| 47 | Neuronal loss in central nervous system (HP:0002529) | 2.65092230 |
| 48 | Failure to thrive in infancy (HP:0001531) | 2.64959470 |
| 49 | Congenital primary aphakia (HP:0007707) | 2.63220788 |
| 50 | Mediastinal lymphadenopathy (HP:0100721) | 2.62811156 |
| 51 | Stomatitis (HP:0010280) | 2.61016246 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.60637108 |
| 53 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.60637108 |
| 54 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.60637108 |
| 55 | Poor suck (HP:0002033) | 2.59928825 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.59532056 |
| 57 | Obstructive lung disease (HP:0006536) | 2.59532056 |
| 58 | Axonal loss (HP:0003447) | 2.54139656 |
| 59 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.53484291 |
| 60 | Amyloidosis (HP:0011034) | 2.51920253 |
| 61 | Oligomenorrhea (HP:0000876) | 2.49817850 |
| 62 | Vacuolated lymphocytes (HP:0001922) | 2.47839527 |
| 63 | Hepatic necrosis (HP:0002605) | 2.47622948 |
| 64 | Ankle clonus (HP:0011448) | 2.46361952 |
| 65 | Prolonged bleeding time (HP:0003010) | 2.43926273 |
| 66 | Anxiety (HP:0000739) | 2.42074613 |
| 67 | EEG with generalized epileptiform discharges (HP:0011198) | 2.41440895 |
| 68 | Mucopolysacchariduria (HP:0008155) | 2.40917817 |
| 69 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.40917817 |
| 70 | Cerebral inclusion bodies (HP:0100314) | 2.40173919 |
| 71 | Decreased circulating renin level (HP:0003351) | 2.36250847 |
| 72 | Increased serum ferritin (HP:0003281) | 2.35038890 |
| 73 | Abnormality of glycolysis (HP:0004366) | 2.34606885 |
| 74 | Increased serum pyruvate (HP:0003542) | 2.34606885 |
| 75 | Progressive neurologic deterioration (HP:0002344) | 2.33103624 |
| 76 | Depression (HP:0000716) | 2.27416632 |
| 77 | Cellulitis (HP:0100658) | 2.26313084 |
| 78 | Cholecystitis (HP:0001082) | 2.25689242 |
| 79 | Abnormal gallbladder physiology (HP:0012438) | 2.25689242 |
| 80 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.22292312 |
| 81 | Increased IgM level (HP:0003496) | 2.21535352 |
| 82 | Gastrointestinal infarctions (HP:0005244) | 2.19800359 |
| 83 | Vasculitis (HP:0002633) | 2.19655853 |
| 84 | Epistaxis (HP:0000421) | 2.18354967 |
| 85 | Hypsarrhythmia (HP:0002521) | 2.17418864 |
| 86 | Abnormal eating behavior (HP:0100738) | 2.17077269 |
| 87 | Vertebral compression fractures (HP:0002953) | 2.16488105 |
| 88 | Meningitis (HP:0001287) | 2.16209843 |
| 89 | Cortical visual impairment (HP:0100704) | 2.14187273 |
| 90 | Interstitial pulmonary disease (HP:0006530) | 2.12978931 |
| 91 | Urticaria (HP:0001025) | 2.12113285 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 2.11775566 |
| 93 | Lactic acidosis (HP:0003128) | 2.10215457 |
| 94 | Gingival bleeding (HP:0000225) | 2.10177487 |
| 95 | Emotional lability (HP:0000712) | 2.08648227 |
| 96 | Abnormality of pain sensation (HP:0010832) | 2.08473367 |
| 97 | Impaired pain sensation (HP:0007328) | 2.08473367 |
| 98 | Autoimmune thrombocytopenia (HP:0001973) | 2.07889635 |
| 99 | Slow saccadic eye movements (HP:0000514) | 2.07824811 |
| 100 | Cerebral hypomyelination (HP:0006808) | 2.07822684 |
| 101 | Limb dystonia (HP:0002451) | 2.06951235 |
| 102 | Unsteady gait (HP:0002317) | 2.06940876 |
| 103 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.06607929 |
| 104 | Optic disc pallor (HP:0000543) | 2.04767764 |
| 105 | Abnormality of binocular vision (HP:0011514) | 2.04706493 |
| 106 | Diplopia (HP:0000651) | 2.04706493 |
| 107 | Episodic fever (HP:0001954) | 2.04587067 |
| 108 | Gaze-evoked nystagmus (HP:0000640) | 2.02619014 |
| 109 | Gingivitis (HP:0000230) | 2.02323593 |
| 110 | Hepatosplenomegaly (HP:0001433) | 2.02242182 |
| 111 | Dysautonomia (HP:0002459) | 2.02070866 |
| 112 | Truncal ataxia (HP:0002078) | 2.01597755 |
| 113 | Apathy (HP:0000741) | 2.01204046 |
| 114 | Supranuclear gaze palsy (HP:0000605) | 2.01198290 |
| 115 | Abnormality of iron homeostasis (HP:0011031) | 2.00067638 |
| 116 | Pulmonary infiltrates (HP:0002113) | 1.99708219 |
| 117 | Spontaneous hematomas (HP:0007420) | 1.99562776 |
| 118 | Recurrent fungal infections (HP:0002841) | 1.98841093 |
| 119 | Delusions (HP:0000746) | 1.98753152 |
| 120 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.98608272 |
| 121 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.98608272 |
| 122 | Abnormality of glycolipid metabolism (HP:0010969) | 1.98608272 |
| 123 | Diminished motivation (HP:0000745) | 1.98494906 |
| 124 | Respiratory failure (HP:0002878) | 1.98046375 |
| 125 | Keratoconjunctivitis sicca (HP:0001097) | 1.97617741 |
| 126 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.96933880 |
| 127 | Amblyopia (HP:0000646) | 1.96168530 |
| 128 | Genital tract atresia (HP:0001827) | 1.94581603 |
| 129 | Nuclear cataract (HP:0100018) | 1.94539356 |
| 130 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.93777315 |
| 131 | Distal lower limb muscle weakness (HP:0009053) | 1.93398288 |
| 132 | Vaginal atresia (HP:0000148) | 1.93268405 |
| 133 | Exercise intolerance (HP:0003546) | 1.92400700 |
| 134 | Obstructive sleep apnea (HP:0002870) | 1.91844969 |
| 135 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.91333758 |
| 136 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.91333758 |
| 137 | Asymmetric septal hypertrophy (HP:0001670) | 1.90045034 |
| 138 | Resting tremor (HP:0002322) | 1.89375957 |
| 139 | Central scotoma (HP:0000603) | 1.89091704 |
| 140 | Recurrent skin infections (HP:0001581) | 1.89038893 |
| 141 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.88310268 |
| 142 | Abnormality of alanine metabolism (HP:0010916) | 1.88310268 |
| 143 | Hyperalaninemia (HP:0003348) | 1.88310268 |
| 144 | Polycythemia (HP:0001901) | 1.86880777 |
| 145 | Specific learning disability (HP:0001328) | 1.85889749 |
| 146 | Polyphagia (HP:0002591) | 1.84560634 |
| 147 | Glomerulonephritis (HP:0000099) | 1.84287784 |
| 148 | Joint swelling (HP:0001386) | 1.84216858 |
| 149 | Broad-based gait (HP:0002136) | 1.84077961 |
| 150 | Encephalitis (HP:0002383) | 1.83921524 |
| 151 | Gastrointestinal stroma tumor (HP:0100723) | 1.83892487 |
| 152 | Tetraplegia (HP:0002445) | 1.83507618 |
| 153 | Spinal canal stenosis (HP:0003416) | 1.82615216 |
| 154 | Dementia (HP:0000726) | 1.82405708 |
| 155 | Hypercortisolism (HP:0001578) | 1.81819423 |
| 156 | Dysostosis multiplex (HP:0000943) | 1.81567038 |
| 157 | Hypertensive crisis (HP:0100735) | 1.81174478 |
| 158 | Acne (HP:0001061) | 1.81166715 |
| 159 | Achilles tendon contracture (HP:0001771) | 1.80183756 |
| 160 | Prolonged neonatal jaundice (HP:0006579) | 1.79843955 |
| 161 | Symptomatic seizures (HP:0011145) | 1.79388878 |
| 162 | Hyperparathyroidism (HP:0000843) | 1.79233739 |
| 163 | Poor coordination (HP:0002370) | 1.79166880 |
| 164 | Abnormality of the Achilles tendon (HP:0005109) | 1.78896820 |
| 165 | Abnormality of complement system (HP:0005339) | 1.78784073 |
| 166 | Distal upper limb amyotrophy (HP:0007149) | 1.78518592 |
| 167 | Upper limb amyotrophy (HP:0009129) | 1.78518592 |
| 168 | Agitation (HP:0000713) | 1.77476355 |
| 169 | Complement deficiency (HP:0004431) | 1.77158077 |
| 170 | Leukodystrophy (HP:0002415) | 1.77118246 |
| 171 | Abnormal pupillary function (HP:0007686) | 1.76716854 |
| 172 | Muscular hypotonia of the trunk (HP:0008936) | 1.76445423 |
| 173 | Increased serum lactate (HP:0002151) | 1.76303392 |
| 174 | Abnormality of the nasal mucosa (HP:0000433) | 1.75366866 |
| 175 | Ragged-red muscle fibers (HP:0003200) | 1.74988845 |
| 176 | Growth hormone excess (HP:0000845) | 1.73133381 |
| 177 | Poor eye contact (HP:0000817) | 1.72019801 |
| 178 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.71914963 |
| 179 | Palpitations (HP:0001962) | 1.71128294 |
| 180 | Hypoventilation (HP:0002791) | 1.70881373 |
| 181 | Fetal akinesia sequence (HP:0001989) | 1.68768665 |
| 182 | Retinal dysplasia (HP:0007973) | 1.67973633 |
| 183 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.67703118 |
| 184 | Dysdiadochokinesis (HP:0002075) | 1.66177007 |
| 185 | Psychosis (HP:0000709) | 1.63751793 |
| 186 | Scanning speech (HP:0002168) | 1.63589915 |
| 187 | Dysmetria (HP:0001310) | 1.61852699 |
| 188 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.61403145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.17888821 |
| 2 | MAP3K12 | 3.32349072 |
| 3 | NTRK3 | 3.18921739 |
| 4 | ERN1 | 3.11583046 |
| 5 | ARAF | 2.75452409 |
| 6 | MAP4K1 | 2.71203080 |
| 7 | MAP2K7 | 2.56957550 |
| 8 | DAPK2 | 2.56913960 |
| 9 | CDK19 | 2.50186489 |
| 10 | TESK2 | 2.45644693 |
| 11 | EPHA4 | 2.40554702 |
| 12 | PRPF4B | 2.34845184 |
| 13 | AKT3 | 2.26249274 |
| 14 | SIK3 | 2.26181723 |
| 15 | IRAK3 | 2.25744855 |
| 16 | DAPK1 | 2.13615992 |
| 17 | PLK2 | 2.11532162 |
| 18 | TBK1 | 2.04259834 |
| 19 | MINK1 | 2.00788760 |
| 20 | CCNB1 | 1.98397306 |
| 21 | TRIB3 | 1.96574347 |
| 22 | TAOK1 | 1.94595378 |
| 23 | MAP3K4 | 1.93114657 |
| 24 | RIPK1 | 1.92127751 |
| 25 | MAP2K3 | 1.85675436 |
| 26 | BRAF | 1.81907780 |
| 27 | TYK2 | 1.81133272 |
| 28 | MAP3K9 | 1.79077632 |
| 29 | NME1 | 1.78918953 |
| 30 | CAMKK2 | 1.77279011 |
| 31 | INSRR | 1.74752113 |
| 32 | TSSK6 | 1.69861872 |
| 33 | TNK2 | 1.68055001 |
| 34 | NTRK1 | 1.66446513 |
| 35 | NME2 | 1.59089258 |
| 36 | MAP3K3 | 1.58817376 |
| 37 | BLK | 1.56751322 |
| 38 | ZAP70 | 1.50503076 |
| 39 | GRK5 | 1.48321952 |
| 40 | PRKD3 | 1.47839716 |
| 41 | STK16 | 1.41135202 |
| 42 | IRAK4 | 1.36573085 |
| 43 | OXSR1 | 1.32750466 |
| 44 | IKBKE | 1.30405353 |
| 45 | EPHB1 | 1.28287492 |
| 46 | SGK223 | 1.24498143 |
| 47 | SGK494 | 1.24498143 |
| 48 | CSK | 1.22582407 |
| 49 | PRKCG | 1.17866104 |
| 50 | SIK1 | 1.16152053 |
| 51 | BCR | 1.15918926 |
| 52 | BMPR2 | 1.08655397 |
| 53 | MYLK | 1.08651528 |
| 54 | CDK5 | 1.07610881 |
| 55 | GRK6 | 1.07442050 |
| 56 | KSR2 | 1.06298832 |
| 57 | JAK1 | 1.05390705 |
| 58 | JAK3 | 1.04783685 |
| 59 | MAP3K2 | 1.04143560 |
| 60 | MARK2 | 1.03928418 |
| 61 | SYK | 1.03439706 |
| 62 | MAP2K4 | 1.03425859 |
| 63 | PAK6 | 1.02418119 |
| 64 | MAPK13 | 1.01655027 |
| 65 | FGFR4 | 1.00088663 |
| 66 | MAP3K14 | 0.99542951 |
| 67 | SGK2 | 0.96553008 |
| 68 | MAPK15 | 0.95943495 |
| 69 | RIPK4 | 0.95588173 |
| 70 | PRKD2 | 0.95366554 |
| 71 | KSR1 | 0.94718403 |
| 72 | CAMK2B | 0.94382543 |
| 73 | TXK | 0.94162144 |
| 74 | PRKCE | 0.93096807 |
| 75 | SMG1 | 0.92874972 |
| 76 | DAPK3 | 0.91877960 |
| 77 | MATK | 0.91606312 |
| 78 | CDK18 | 0.90711914 |
| 79 | CAMK2A | 0.90301493 |
| 80 | CAMK2D | 0.89892912 |
| 81 | CDK14 | 0.86493234 |
| 82 | TESK1 | 0.86485111 |
| 83 | LIMK1 | 0.85782900 |
| 84 | IKBKB | 0.85416054 |
| 85 | MAP3K1 | 0.84630099 |
| 86 | MAPK12 | 0.84253410 |
| 87 | PDK1 | 0.82271375 |
| 88 | CAMKK1 | 0.81495324 |
| 89 | KDR | 0.80749353 |
| 90 | JAK2 | 0.80210948 |
| 91 | PTK2B | 0.79872431 |
| 92 | UHMK1 | 0.77512663 |
| 93 | CDK15 | 0.77498003 |
| 94 | LMTK2 | 0.77482675 |
| 95 | FGR | 0.76611730 |
| 96 | PDK4 | 0.76451889 |
| 97 | PDK3 | 0.76451889 |
| 98 | TAOK3 | 0.75255601 |
| 99 | SIK2 | 0.75121602 |
| 100 | HCK | 0.75058515 |
| 101 | ABL2 | 0.74236628 |
| 102 | WNK3 | 0.73427402 |
| 103 | HIPK2 | 0.73166417 |
| 104 | MOS | 0.72792670 |
| 105 | BTK | 0.72344043 |
| 106 | FER | 0.70213992 |
| 107 | PRKCH | 0.69932580 |
| 108 | DDR2 | 0.68925063 |
| 109 | ICK | 0.67951161 |
| 110 | IRAK2 | 0.67461550 |
| 111 | PDK2 | 0.67391308 |
| 112 | EIF2AK3 | 0.67339270 |
| 113 | CDK11A | 0.66725870 |
| 114 | MAPK11 | 0.66110309 |
| 115 | MAP2K1 | 0.65840352 |
| 116 | BMX | 0.65583515 |
| 117 | LYN | 0.61775203 |
| 118 | MARK1 | 0.60558618 |
| 119 | MAP3K13 | 0.59350805 |
| 120 | MAP3K5 | 0.59209029 |
| 121 | PINK1 | 0.59160531 |
| 122 | LCK | 0.57961656 |
| 123 | DYRK1A | 0.57527749 |
| 124 | PRKG2 | 0.57326674 |
| 125 | NEK1 | 0.56273300 |
| 126 | WNK4 | 0.55843001 |
| 127 | CSF1R | 0.55695991 |
| 128 | SCYL2 | 0.54587902 |
| 129 | CAMK2G | 0.54526932 |
| 130 | KIT | 0.54300419 |
| 131 | MAP3K11 | 0.54079891 |
| 132 | BMPR1B | 0.53389435 |
| 133 | ADRBK1 | 0.52308068 |
| 134 | PHKG2 | 0.51569482 |
| 135 | PHKG1 | 0.51569482 |
| 136 | PIM2 | 0.51303805 |
| 137 | ADRBK2 | 0.51146846 |
| 138 | TTN | 0.50658484 |
| 139 | TAOK2 | 0.48804282 |
| 140 | TGFBR2 | 0.47753001 |
| 141 | MAP2K6 | 0.47092318 |
| 142 | CDC42BPA | 0.47082721 |
| 143 | NEK6 | 0.46412666 |
| 144 | PRKCI | 0.44901515 |
| 145 | SGK3 | 0.44639658 |
| 146 | FYN | 0.44497923 |
| 147 | PAK1 | 0.44480079 |
| 148 | PASK | 0.44478500 |
| 149 | GRK7 | 0.44435018 |
| 150 | PAK3 | 0.43526807 |
| 151 | PRKACA | 0.43005831 |
| 152 | PRKD1 | 0.42550170 |
| 153 | MAPK4 | 0.42284598 |
| 154 | DYRK1B | 0.42142494 |
| 155 | FES | 0.41114043 |
| 156 | RPS6KA2 | 0.40942404 |
| 157 | MAPKAPK3 | 0.40392360 |
| 158 | STK38 | 0.39791178 |
| 159 | TNIK | 0.39259241 |
| 160 | MUSK | 0.39038509 |
| 161 | CAMK1 | 0.38297291 |
| 162 | BCKDK | 0.37754545 |
| 163 | NTRK2 | 0.37157971 |
| 164 | PDPK1 | 0.35539249 |
| 165 | RAF1 | 0.35305570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.36434452 |
| 2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.93651970 |
| 3 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 3.12556845 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 3.05171413 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.80737597 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.50171851 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.42086145 |
| 8 | Insulin secretion_Homo sapiens_hsa04911 | 2.33112863 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.31569050 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.28779122 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 2.28098433 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.25830081 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 2.18944138 |
| 14 | Circadian entrainment_Homo sapiens_hsa04713 | 2.18940460 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.11652861 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.06960890 |
| 17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.99350067 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.97382933 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.92243937 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.90238032 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.82206578 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.80388943 |
| 23 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.79418988 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.76206890 |
| 25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.72603946 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.72555248 |
| 27 | Alzheimers disease_Homo sapiens_hsa05010 | 1.70685683 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.70682563 |
| 29 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.70102258 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.64364821 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.59881088 |
| 32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.59716076 |
| 33 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.57860958 |
| 34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.53153993 |
| 35 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.53070919 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.52061548 |
| 37 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.49861202 |
| 38 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.48677097 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.48640568 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 1.45218016 |
| 41 | Cocaine addiction_Homo sapiens_hsa05030 | 1.44282658 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.43816691 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.43659331 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.36522519 |
| 45 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.34961450 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 1.34608841 |
| 47 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34608324 |
| 48 | Salivary secretion_Homo sapiens_hsa04970 | 1.32014017 |
| 49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.31086986 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.30766380 |
| 51 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.30662946 |
| 52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.30225237 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24421817 |
| 54 | Huntingtons disease_Homo sapiens_hsa05016 | 1.23558217 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 1.23119485 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22000790 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.19388023 |
| 58 | Proteasome_Homo sapiens_hsa03050 | 1.19256580 |
| 59 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17315991 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.16147891 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.14088151 |
| 62 | Renin secretion_Homo sapiens_hsa04924 | 1.13377608 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 1.11535029 |
| 64 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.09403799 |
| 65 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.09373748 |
| 66 | Long-term depression_Homo sapiens_hsa04730 | 1.09270223 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 1.08946611 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 1.08674524 |
| 69 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.07835273 |
| 70 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06904070 |
| 71 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.05534524 |
| 72 | Asthma_Homo sapiens_hsa05310 | 1.05260158 |
| 73 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.04154267 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04011936 |
| 75 | Measles_Homo sapiens_hsa05162 | 1.01486086 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00753385 |
| 77 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.00215290 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.99990089 |
| 79 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.99033140 |
| 80 | Phototransduction_Homo sapiens_hsa04744 | 0.97240593 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.96205823 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95992774 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95733484 |
| 84 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.95622546 |
| 85 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95128185 |
| 86 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.94910979 |
| 87 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94679465 |
| 88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92005142 |
| 89 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91824106 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.91185278 |
| 91 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.89807258 |
| 92 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84776592 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.84692893 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.83325496 |
| 95 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.83154640 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.81348390 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80803040 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80572396 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.78909589 |
| 100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78001689 |
| 101 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.77444906 |
| 102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76134793 |
| 103 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.75274342 |
| 104 | Hepatitis B_Homo sapiens_hsa05161 | 0.74049665 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74019167 |
| 106 | Apoptosis_Homo sapiens_hsa04210 | 0.73398754 |
| 107 | Platelet activation_Homo sapiens_hsa04611 | 0.72843113 |
| 108 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71871827 |
| 109 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.69876989 |
| 110 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.68656363 |
| 111 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68387003 |
| 112 | Gap junction_Homo sapiens_hsa04540 | 0.67103088 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66935261 |
| 114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65599924 |
| 115 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65580426 |
| 116 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65526937 |
| 117 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.65323109 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.64968905 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63601159 |
| 120 | Bladder cancer_Homo sapiens_hsa05219 | 0.62003300 |
| 121 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59815886 |
| 122 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.59190852 |
| 123 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58722316 |
| 124 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58002019 |
| 125 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56374093 |
| 126 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56043902 |
| 127 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55245835 |
| 128 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.54542207 |
| 129 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54320879 |
| 130 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48215031 |
| 131 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48180754 |
| 132 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46412161 |
| 133 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.46321569 |
| 134 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.44472975 |
| 135 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43597006 |
| 136 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43576200 |
| 137 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.43443319 |
| 138 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42998847 |
| 139 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42426053 |
| 140 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.42386887 |
| 141 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.41045840 |
| 142 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.39880435 |
| 143 | Alcoholism_Homo sapiens_hsa05034 | 0.39739912 |
| 144 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39724063 |
| 145 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39138963 |
| 146 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.36767847 |
| 147 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33967026 |
| 148 | Melanogenesis_Homo sapiens_hsa04916 | 0.32226407 |
| 149 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.31737927 |
| 150 | Carbon metabolism_Homo sapiens_hsa01200 | 0.30517192 |
| 151 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.30348424 |
| 152 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.30218806 |
| 153 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29356794 |
| 154 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28742513 |
| 155 | Endocytosis_Homo sapiens_hsa04144 | 0.28274709 |
| 156 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27904549 |
| 157 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24764052 |
| 158 | Glioma_Homo sapiens_hsa05214 | 0.24179425 |
| 159 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.22065171 |
| 160 | Prion diseases_Homo sapiens_hsa05020 | 0.19198319 |
| 161 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.19160053 |
| 162 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.19001537 |
| 163 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.17667129 |
| 164 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.17149166 |
| 165 | Axon guidance_Homo sapiens_hsa04360 | 0.16786187 |
| 166 | Metabolic pathways_Homo sapiens_hsa01100 | 0.16644057 |

